INDOBORAX NSI Week ended 31 Jul 2026

Weekly Investor Report

Indo Borax & Chemicals Limited · Basic Materials · Chemicals

Open interactive chart View report data
Latest close 374.9 INR
-9.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 27.0% above the Trend Line and sits at 64.8% of its 52-week range. The latest completed week returned -9.9%, after a 4.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.

Setup score 62 out of 100
Latest Close 374.9 INR 31 Jul 2026
1W Return -9.9% latest completed week
4W Return 4.2% short-term follow-through
12W Return 38.2% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • The trend backdrop is active with a 12-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 8 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -9.9% Latest completed week; four-week move 4.2%. Indicator stack 80/78 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 51/100 40 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 27.0% above the Trend Line and sits at 64.8% of its 52-week range. The latest completed week returned -9.9%, after a 4.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9612-week average 0.74

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.96Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 4.2% over four weeks, 38.2% over 12 weeks, and 33.4% over one year. The current trend has remained active for 12 consecutive weeks.

Performance by holding period

1W-9.9%
4W4.2%
12W38.2%
26W52.0%
52W33.4%
Active trend streak12 weeks
Active weeks in one year36
Trend breadth69.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.39Latest activity-pressure read.
Pressure change40.9%Four-week change in activity pressure.
Leadership36.88Latest relative-leadership reading.
RS change-2.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength79/100Blend of value, momentum, and quality. Underlying universe rank 22; rank 1 is best.
Value36/100Relative valuation strength. Underlying universe rank 65; rank 1 is best.
Quality91/100Profitability and accounting quality. Underlying universe rank 10; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth78/100Revenue and earnings growth. Underlying universe rank 23; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework29/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
26.6x
Price divided by trailing earnings.
Price / sales
6.2x
Market value relative to trailing revenue.
EV / EBITDA
19.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
47.3%
Gross profit retained from each unit of revenue.
Operating margin
19.0%
Operating profit retained from revenue.
Free-cash-flow margin
40.3%
Free cash flow generated from revenue.
Return on invested capital
8.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
22.9%
Latest one-year revenue growth.
EPS growth
18.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
9.9%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
9.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 40 relevant articles.

6 positive · 32 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-18.1%Distance below the 52-week high.
13-week volatility7.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+17.6%Week of 22 May.
Worst week-10.6%Week of 19 Jun.
Latest week-9.9%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains9
Flat weeks0
Modest losses9
Sharp losses2
Recent vol7.9%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape61/100

Trend, activity pressure, participation, and risk combine to a 61/100 tape read.

 Indicator analysis83/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.96; 8 reversal markers Factors74/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 27; Small Cap Core rank 49 SVQF29/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1123.5 of 1590 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 40 relevant articles.

Is Air Products and Chemicals (APD) Undervalued After Its Latest Earnings Loss? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026374.9 INR-9.9%295.1 INR215.2 INR1.3936.88926.5KOn
24 Jul 2026416.1 INR-2.5%291.6 INR213.9 INR1.4956.9212.9MOn
17 Jul 2026427.0 INR2.6%286.5 INR212.3 INR1.2958.882.6MOn
10 Jul 2026416.1 INR15.7%281.3 INR210.4 INR1.0757.752.2MOn
3 Jul 2026359.6 INR3.1%276.6 INR208.5 INR0.9937.92372.0KOn
26 Jun 2026348.9 INR4.5%273.0 INR207.1 INR1.1136.500On
19 Jun 2026333.8 INR-10.6%269.4 INR205.6 INR1.3032.3726.9KOn
12 Jun 2026373.5 INR1.6%266.4 INR204.3 INR1.5652.19120.8KOn
5 Jun 2026367.4 INR6.7%262.7 INR202.8 INR1.5253.52113.9KOn
29 May 2026344.2 INR6.7%258.9 INR201.2 INR1.4144.87699.1KOn
22 May 2026322.6 INR17.6%256.4 INR199.8 INR1.4036.673.3MOn
15 May 2026274.5 INR1.2%253.7 INR198.5 INR0.9018.02588.8KOn
8 May 2026271.2 INR-2.3%252.3 INR197.5 INR0.6414.99299.7KOff
1 May 2026277.6 INR13.4%251.1 INR196.5 INR0.4319.38957.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.